Cargando…

Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model

Renal impairment associated with chronic kidney disease (CKD) causes the buildup of uremic toxins that are deleterious to patient health. Current therapies that manage toxin accumulation in CKD offer an incomplete therapeutic effect against toxins such as para-cresol (p-cresol) and p-cresyl sulfate....

Descripción completa

Detalles Bibliográficos
Autores principales: Stuivenberg, Gerrit A., Chmiel, John A., Akouris, Polycronis P., Burton, Jeremy P., Reid, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769938/
https://www.ncbi.nlm.nih.gov/pubmed/36321825
http://dx.doi.org/10.1128/msphere.00446-22
_version_ 1784854482242240512
author Stuivenberg, Gerrit A.
Chmiel, John A.
Akouris, Polycronis P.
Burton, Jeremy P.
Reid, Gregor
author_facet Stuivenberg, Gerrit A.
Chmiel, John A.
Akouris, Polycronis P.
Burton, Jeremy P.
Reid, Gregor
author_sort Stuivenberg, Gerrit A.
collection PubMed
description Renal impairment associated with chronic kidney disease (CKD) causes the buildup of uremic toxins that are deleterious to patient health. Current therapies that manage toxin accumulation in CKD offer an incomplete therapeutic effect against toxins such as para-cresol (p-cresol) and p-cresyl sulfate. Probiotic therapies can exploit the wealth of microbial diversity to reduce toxin accumulation. Using in vitro culture techniques, strains of lactobacilli and bifidobacteria from a 24-strain synbiotic were investigated for their ability to remove p-cresol. Four strains of bifidobacteria internalized p-cresol from the extracellular environment. The oral supplementation of these toxin-clearing probiotics was more protective than control strains in a Drosophila melanogaster toxicity model. Bifidobacterial supplementation was also associated with higher abundance of lactobacilli in the gut microbiota of p-cresol-exposed flies. The present findings suggest that these strains might reduce p-cresol in the gut in addition to increasing the prevalence of other beneficial bacteria, such as lactobacilli, and should be tested clinically to normalize the dysbiotic gut microbiota observed in CKD patients. IMPORTANCE Chronic kidney disease (CKD) affects approximately 10% of the global population and has limited treatment options. The accumulation of gut microbiota-derived uremic toxins, such as para-cresol (p-cresol) and p-cresyl sulfate, is associated with the onset of comorbidities (i.e., atherosclerosis and cognitive disorders) in CKD. Unfortunately, dialysis, the gold standard therapy is unable to remove these toxins from the bloodstream due to their highly protein-bound nature. Some strains of Bifidobacterium have metabolic properties that may be useful in managing uremic toxicity. Using a Drosophila model, the present work highlights why dosing with certain probiotic strains may be clinically useful in CKD management.
format Online
Article
Text
id pubmed-9769938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-97699382022-12-22 Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model Stuivenberg, Gerrit A. Chmiel, John A. Akouris, Polycronis P. Burton, Jeremy P. Reid, Gregor mSphere Research Article Renal impairment associated with chronic kidney disease (CKD) causes the buildup of uremic toxins that are deleterious to patient health. Current therapies that manage toxin accumulation in CKD offer an incomplete therapeutic effect against toxins such as para-cresol (p-cresol) and p-cresyl sulfate. Probiotic therapies can exploit the wealth of microbial diversity to reduce toxin accumulation. Using in vitro culture techniques, strains of lactobacilli and bifidobacteria from a 24-strain synbiotic were investigated for their ability to remove p-cresol. Four strains of bifidobacteria internalized p-cresol from the extracellular environment. The oral supplementation of these toxin-clearing probiotics was more protective than control strains in a Drosophila melanogaster toxicity model. Bifidobacterial supplementation was also associated with higher abundance of lactobacilli in the gut microbiota of p-cresol-exposed flies. The present findings suggest that these strains might reduce p-cresol in the gut in addition to increasing the prevalence of other beneficial bacteria, such as lactobacilli, and should be tested clinically to normalize the dysbiotic gut microbiota observed in CKD patients. IMPORTANCE Chronic kidney disease (CKD) affects approximately 10% of the global population and has limited treatment options. The accumulation of gut microbiota-derived uremic toxins, such as para-cresol (p-cresol) and p-cresyl sulfate, is associated with the onset of comorbidities (i.e., atherosclerosis and cognitive disorders) in CKD. Unfortunately, dialysis, the gold standard therapy is unable to remove these toxins from the bloodstream due to their highly protein-bound nature. Some strains of Bifidobacterium have metabolic properties that may be useful in managing uremic toxicity. Using a Drosophila model, the present work highlights why dosing with certain probiotic strains may be clinically useful in CKD management. American Society for Microbiology 2022-11-02 /pmc/articles/PMC9769938/ /pubmed/36321825 http://dx.doi.org/10.1128/msphere.00446-22 Text en Copyright © 2022 Stuivenberg et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Stuivenberg, Gerrit A.
Chmiel, John A.
Akouris, Polycronis P.
Burton, Jeremy P.
Reid, Gregor
Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model
title Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model
title_full Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model
title_fullStr Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model
title_full_unstemmed Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model
title_short Probiotic Bifidobacteria Mitigate the Deleterious Effects of para-Cresol in a Drosophila melanogaster Toxicity Model
title_sort probiotic bifidobacteria mitigate the deleterious effects of para-cresol in a drosophila melanogaster toxicity model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769938/
https://www.ncbi.nlm.nih.gov/pubmed/36321825
http://dx.doi.org/10.1128/msphere.00446-22
work_keys_str_mv AT stuivenberggerrita probioticbifidobacteriamitigatethedeleteriouseffectsofparacresolinadrosophilamelanogastertoxicitymodel
AT chmieljohna probioticbifidobacteriamitigatethedeleteriouseffectsofparacresolinadrosophilamelanogastertoxicitymodel
AT akourispolycronisp probioticbifidobacteriamitigatethedeleteriouseffectsofparacresolinadrosophilamelanogastertoxicitymodel
AT burtonjeremyp probioticbifidobacteriamitigatethedeleteriouseffectsofparacresolinadrosophilamelanogastertoxicitymodel
AT reidgregor probioticbifidobacteriamitigatethedeleteriouseffectsofparacresolinadrosophilamelanogastertoxicitymodel